Gastrointestinal symptoms arise because semaglutide slows gastric emptying, leading to feelings of fullness, bloating, and upper abdominal discomfort
The pharmacokinetics of peptide-based medications, including how they distribute through tissue and how quickly they are cleared, are influenced by body mass
Usually these folks are not GSH allergic, but the pathways need to be clear first
They are also negotiating autonomy, identity, and belonging
The surging demandand high costof GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, originally developed for diabetes but now widely used for weight loss, presents a complex balancing act for insurers to control near-term drug costs and manage long-term health outcomes